| Authors: |
Leestemaker Y; Division of Cell Biology II, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Chemical Immunology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands., de Jong A; Division of Cell Biology II, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Witting KF; Division of Cell Biology II, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Chemical Immunology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands., Penning R; Biomolecular Mass Spectrometry and Proteomics, Utrecht University, 3584 CH Utrecht, the Netherlands., Schuurman K; Division of Cell Biology II, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Rodenko B; Division of Cell Biology II, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Zaal EA; Biomolecular Mass Spectrometry and Proteomics, Utrecht University, 3584 CH Utrecht, the Netherlands., van de Kooij B; Division of Immunology, The Netherlands Cancer Institute, 2300 RC Amsterdam, the Netherlands., Laufer S; Institute of Pharmacy, University of Tübingen, 72076 Tübingen, Germany., Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Utrecht University, 3584 CH Utrecht, the Netherlands., Borst J; Division of Immunology, The Netherlands Cancer Institute, 2300 RC Amsterdam, the Netherlands., Scheper W; Department of Clinical Genetics and Alzheimer Center, VU University Medical Center, 1081 HV Amsterdam, the Netherlands; Department of Functional Genome Analysis, VU University, 1081 HV Amsterdam, the Netherlands., Berkers CR; Biomolecular Mass Spectrometry and Proteomics, Utrecht University, 3584 CH Utrecht, the Netherlands. Electronic address: c.r.berkers@uu.nl., Ovaa H; Division of Cell Biology II, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Chemical Immunology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands. Electronic address: h.ovaa@lumc.nl. |
